Answers are grounded in this paper and cite their sources.
Based on cortical miRNA levels, PD brains were accurately classified from non-diseased brains. Additionally, the PDD miRNA profile exhibited a more severe pattern of alteration among those differentially expressed in PD. To evaluate the clinical utility of miRNAs as potential clinical biomarkers, further characterization and testing of brain-related miRNA alterations in peripheral biofluids is warranted.
No takes yet. Share an insight, caveat, or question.
Hoss et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: